Literature DB >> 6594386

HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).

C Papasteriades, M N Alevizaki-Harhalaki, J Economidou, D G Ikkos.   

Abstract

HLA-A and B-antigens were tested by a standard microlymphocytotoxicity technique in 126 controls and 225 thyrotoxic patients of Greek origin [173 with Graves' disease and 52 with toxic nodular goiter (TNG)]. We found: i) an increased frequency of HLA-B8 (21.4% versus 7.1%) and a decreased frequency of HLA-B12 (2.9% versus 18.2%) in Graves' disease when compared with controls; ii) no differences in the distribution of HLA-A, -B antigens in TNG, when compared with either controls or Graves' disease. These findings suggest that the associations between HLA-A, -B antigens and Graves' disease in Greek patients are similar to those reported in other caucasians. The absence of any correlation between HLA-A, -B and TNG provides additional laboratory evidence that TNG and Graves' disease represent different entities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6594386     DOI: 10.1007/BF03351003

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  [HLA B8 and Graves' disease (author's transl)].

Authors:  C Jaffiol; J Seignalet; L Baldet; M Robin; H Lapinski; J Mirouze
Journal:  Ann Endocrinol (Paris)       Date:  1976 Jul-Aug       Impact factor: 2.478

2.  HL-A antigens and thyrotoxicosis.

Authors:  S D Nelson; J E Pollet
Journal:  Tissue Antigens       Date:  1975-02

3.  Genetic heterogeneity in thyrotoxicosis patients with and without endocrine ophthalmopathy.

Authors:  G Schernthaner; H Ludwig; W R Mayr; R Höfer
Journal:  Diabete Metab       Date:  1977-09

4.  HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease.

Authors:  F C Grumet; R O Payne; J Konishi; J P Kriss
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

5.  HLA-BW35 and B5 in Japanese patients with Graves' disease.

Authors:  A Kawa; S Nakamura; M Nakazawa; S Sakaguchi; T Kawabata; Y Maeda; T Kanehisa
Journal:  Acta Endocrinol (Copenh)       Date:  1977-12

6.  Graves' disease and HLA: clinical and epidemiologic associations.

Authors:  N R Farid; E Stone; G Johnson
Journal:  Clin Endocrinol (Oxf)       Date:  1980-12       Impact factor: 3.478

7.  HLA antigens in Graves' disease.

Authors:  K Bech; B Lumholtz; J Nerup; M Thomsen; P Platz; L P Ryder; A Svejgaard; K Siersbaek-Nielsen; J M Hansen; J H Larsen
Journal:  Acta Endocrinol (Copenh)       Date:  1977-11

8.  A study of human leukocyte D locus related antigens in Graves' disease.

Authors:  N R Farid; L Sampson; E P Noel; J M Barnard; R Mandeville; B Larsen; W H Marshall; N D Carter
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

9.  HL-A antigens in Japanese Patients with Graves' disease.

Authors:  F C Grumet; R O Payne; J Konishi; T Mori; J P Kriss
Journal:  Tissue Antigens       Date:  1975-11

10.  Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?

Authors:  R S Brown; I M Jackson; S L Pohl; S Reichlin
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.